Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
- Response deadline
- Nov 5, 2026 Due in 93 days
- Date posted
- Aug 3, 2026
- Source
- Open notice
Description
The focus of this notice of funding opportunity (NOFO) is to produce insights into disease detection and prevention strategies, burden, severity, diagnostics, treatment, and outcomes of infectious diseases in international travelers. Timely surveillance and sentinel detection are essential for collecting actionable data. The research should:Address public health questions that improve the speed of outbreak detection.Help develop guidelines and recommendations to improve patient care.Enhance understanding of the natural history of disease.Optimize genomic surveillance as well as diagnostic and treatment strategies.Advance the global health security of the United States.This NOFO will have two components:Component A – Clinic-based sentinel network.Component B – Sentinel detection in international transportation hubs.You may apply for Component A, B, or both. If your application for both Component A and B is ranked top, Component B will be awarded.
Classifications
- NAICS93.084
Documents (1)
- rfa-ck-26-035-v3.pdfapplication/pdf1.2 MBNot yet available
Contacts
Similar contracts
- Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.Due Jul 17, 2026
- Building National Partnerships for the Prevention of Emerging and Reemerging Infectious DiseasesDue Jul 1, 2026
- Increasing awareness and knowledge of Alpha-gal Syndrome in the United StatesDue Jul 9, 2026
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Due Feb 8, 2028
- NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food SpecimensDue Apr 1, 2027
- Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not AllowedDue Apr 1, 2027